Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

This study has been completed.
Information provided by (Responsible Party):
Valneva Austria GmbH Identifier:
First received: January 4, 2008
Last updated: October 18, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2004
  Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)